Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
PR Newswire —
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks the largest biotech IPO on the Hong...